Thalidomide
Back to searchMolecule Structure
Scientific Name
Thalidomide
Description of the Drug
Thalidomide is a medication used to treat cancers, particularly newly diagnosed multiple myeloma, and erythema nodosum leprosum.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01041
http://www.drugbank.ca/drugs/DB01041
Brand Name(s)
Talidex, Thalomid
Company Owner(s)
Celgene Corp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
CRL4(CRBN) E3 ubiquitin ligase | PROTEIN COMPLEX | INHIBITOR | CHEMBL3833061 |
Clinical Trial(s)
Unichem Links
Atlas | thalidomide | |
SureChEMBL | SCHEMBL7581 | |
PharmGKB | PA451644 | |
Human Metabolome Database | HMDB0015175 | |
DrugBank | DB01041 | |
PubChem: Thomson Pharma | 14798889 | |
PubChem | 5426 | |
Mcule | MCULE-6327754946 | |
LINCS | LSM-1914 | |
Nikkaji | J4.101G | |
BindingDB | 50070114 | |
EPA CompTox Dashboard | DTXSID9022524 | |
DrugCentral | 2616 | |
Brenda | 160374 | |
ChemicalBook | CB0311476 | |
Guide to Pharmacology | 7327 | |
rxnorm | THALIDOMIDE | THALOMID |
PubChem: Drugs of the Future | 12013404 | |
KEGG Ligand | C07910 | |
ChEBI | 74947 |